Skip to content
healthcare.dev

Fludarabine phosphate

NDC 45963-609, Fludarabine phosphate, injection, powder, lyophilized, for solution, from Actavis Pharma, Inc..

Product NDC
45963-609
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078610
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45963-609 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FLUDARABINE PHOSPHATE50 mg/2mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
45963-609-55459630609551 VIAL, GLASS in 1 CARTON (45963-609-55) / 2 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3adca34b-4f65-4e21-8058-3c01fc7fc9bb
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=45963-609

Use it

Look up 45963-609 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45963-609 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45963-609. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.